Cyfuse Biomedical

Cyfuse Biomedical develops Bio-3D printing technologies and instruments for regenerative medicine, best known for its Regenova Bio-3D Printer and the Kenzan spheroid-based bioprinting method. The company manufactures scaffold-free, cell-assembled tissue constructs by fusing multicellular spheroids to create transplantable tissues and in vitro models for drug discovery and research. Cyfuse primarily serves academic, clinical and commercial research customers worldwide from its headquarters in Tokyo, Japan.